Table 3.
Acceptability between the five kinds of antipsychotic groups after 6–8 weeks of treatment (N, %)
| Groups | N | Disc. of initially assigned APs | Use of concomitant APs | Maintaining initially assigned APs |
|---|---|---|---|---|
| Aripiprazole | 39 | 16 (0.41) | 8 (0.21) | 15 (0.38) |
| Risperidone | 43 | 20 (0.47) | 3 (0.069) | 20 (0.47) |
| Quetiapine | 39 | 12 (0.31) | 4 (0.10) | 23 (0.59)a |
| Olanzapine | 35 | 14 (0.4) | 0 | 21 (0.60)a |
| Ziprasidone | 19 | 12 (0.63) | 2 (0.11) | 5 (0.26) |
Values are represented as N: number of patients; APs: antipsychotics; Disc.: discontinuation
aComparison of quetiapine and olanzapine with ziprasidone, both with P < 0.05